1. Home
  2. MORN vs CYTK Comparison

MORN vs CYTK Comparison

Compare MORN & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morningstar Inc.

MORN

Morningstar Inc.

HOLD

Current Price

$213.60

Market Cap

8.8B

Sector

Finance

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$65.95

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MORN
CYTK
Founded
1984
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
8.0B
IPO Year
2005
2004

Fundamental Metrics

Financial Performance
Metric
MORN
CYTK
Price
$213.60
$65.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
16
Target Price
$333.33
$82.38
AVG Volume (30 Days)
422.6K
2.2M
Earning Date
02-25-2026
02-26-2026
Dividend Yield
0.93%
N/A
EPS Growth
16.18
N/A
EPS
8.80
N/A
Revenue
$2,395,400,000.00
$87,211,000.00
Revenue This Year
$8.79
$346.43
Revenue Next Year
$7.52
$57.69
P/E Ratio
$24.51
N/A
Revenue Growth
7.76
2609.26
52 Week Low
$202.89
$29.31
52 Week High
$335.21
$70.98

Technical Indicators

Market Signals
Indicator
MORN
CYTK
Relative Strength Index (RSI) 46.55 56.88
Support Level $209.41 $58.85
Resistance Level $220.30 $64.43
Average True Range (ATR) 5.21 2.90
MACD -0.18 0.24
Stochastic Oscillator 41.47 58.94

Price Performance

Historical Comparison
MORN
CYTK

About MORN Morningstar Inc.

Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: